Mochatrade secured $5.56 million in funding through pre-seed and seed rounds led by Y Combinator and CoinFund to grow its India-focused trading platform. The platform allows users to deposit Indian rupees and trade perpetual contracts linked to over 50 U.S. stocks and other assets like Bitcoin and gold, without transferring shares. Mochatrade plans to use the funds to enhance its trading engine, risk controls, and expand its user base, while developing new features like U.S. stock options and social trading, pending regulatory approval. The company operates under India's anti-money-laundering regulations but is not yet authorized for securities business.
Mochatrade's recent funding round is the subject, provided here with Pluang's cryptocurrency market context. For readers following major cryptocurrencies, 38 of 50 priced assets rose and 11 fell today. Notable movers include BAL at Rp16.297 (+11.14%), EOS at Rp12.649 (+8.13%), and EGLD at Rp61.081 (+4.60%) with 100% buy order activity. This data is as of Oct 28, 2026 21:22 WIB.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
